HALO logo
halo search icon
MetaVia Inc.

US$2.89

Price Change Indicator
1.01 (53.72%)
MetaVia Inc.
MTVA · NAS

MetaVia Inc.

Start Trading MTVA for Free

US$2.89

Price Arrow1.01 (53.72%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)HALO AllHALO Consensus ValueHALO Earnings MomentumHALO Growth
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MetaVia Inc. Overview

MTVA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MTVA

icon
icon

Telephone

1.857.702.9600

icon

Address

Suite 210, 545 Concord Avenue, Cambridge, MA 02138

Description

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MTVA Price Chart

Key Stats

Market Cap

US$9.71M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.97 - 19.03

Trade Value (12mth)

US$480,064.00

1 week

69.37%

1 month

17.5%

YTD

-80.33%

1 year

-80.48%

All time high

1424940.00

Key Fundamentals

EPS 3 yr Growth

-98.50%

EBITDA Margin

0.00%

Operating Cashflow

-$16m

Free Cash Flow Return

-233.20%

ROIC

-192.70%

Interest Coverage

0.00

Quick Ratio

1.90

Other Data

Shares Outstanding (Fully Diluted)

5m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MTVA Announcements

Latest Announcements

DateAnnouncements
18 May 26
15 May 26
15 May 26
15 May 26
15 May 26

MTVA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-27.05-39.13-7.35locklocklock
EPS (Fully Diluted)
 $locklocklocklock-27.05-39.13-7.35locklocklock
Growth
 %locklocklocklock94.3-44.781.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of MetaVia Inc. (MTVA:NAS)?
Halo FAQ
The current share price of MetaVia Inc. (MTVA:NAS) is USD$2.89.
What is the 52-week high share price for MetaVia Inc. (MTVA:NAS)?
Halo FAQ
The 52-week high share price for MetaVia Inc. (MTVA:NAS) is USD$19.03.
What is the 52-week low share price for MetaVia Inc. (MTVA:NAS)?
Halo FAQ
The 52-week low share price for MetaVia Inc. (MTVA:NAS) is USD$0.97.
What is the dividend yield for MetaVia Inc. (MTVA:NAS)?
Halo FAQ
MetaVia Inc. (MTVA:NAS) does not pay a dividend.
What was MetaVia Inc. (MTVA:NAS) last dividend payment?
Halo FAQ
MetaVia Inc. (MTVA:NAS) does not pay a dividend.
What is the franking level for MetaVia Inc. (MTVA:NAS)?
Halo FAQ
MetaVia Inc. (MTVA:NAS) has a franking level of 0.00%.
In which sector is MetaVia Inc. (MTVA:NAS) classified?
Halo FAQ
MetaVia Inc. (MTVA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial